136 Results

People

  1. Morrow
    Morrow
  2. Hudis
    Hudis
  3. Pike
    Pike
  4. Morris
    Morris
  5. Norton
    Norton
  6. Dickler
    Dickler
  7. Dershaw
    Dershaw
  8. Bernstein
    Bernstein
  9. Hann
    Hann
  10. Robson
    Robson

Groups

  1. Department of Medicine (46)
  2. Solid Tumor Oncology Division (41)
  3. Breast Medicine Service (38)
  4. Survivorship Research (38)
  5. Surgery (36)
  6. Epidemiology and Biostatistics (32)
  7. Population Sciences Research Program (31)
  8. Radiology, Department of (21)
  9. Epidemiology Service (17)
  10. Body Imaging Service (13)
  1. "postmenopause"
Formats
  1. Journal Article (128)
  2. Editorial (2)
  3. Miscellaneous (2)
  4. Review (2)
  5. Conference Paper (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (46)
  2. Solid Tumor Oncology Division (41)
  3. Breast Medicine Service (38)
  4. Survivorship Research (38)
  5. Surgery (36)
  6. Epidemiology and Biostatistics (32)

More Groups

People
  1. Monica Morrow (13)
  2. Clifford Hudis (12)
  3. Malcolm Pike (11)
  4. Elizabeth Morris (10)
  5. Larry Norton (10)
  6. Maura Dickler (9)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (11)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Breast Cancer Research and Treatment (8)
  2. Journal of Clinical Oncology (8)
  3. Annals of Surgical Oncology (7)
  4. American Journal of Roentgenology (5)
  5. Radiology (5)
  6. Women's Oncology Review (5)

More Publications

Publishers
  1. Springer (21)
  2. Elsevier Inc. (18)
  3. American Association for Cancer Research (9)
  4. American Society of Clinical Oncology (8)
  5. Oxford University Press (8)
  6. Nature Publishing Group (7)

More Publishers

Results (136)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors
    Journal Article

    Zattarin, E.; Mariani, L.; Menichetti, A.; Leporati, R.; Provenzano, L.; Ligorio, F.; Fucà, G.; Lobefaro, R.; Lalli, L.; Vingiani, A.; more...
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Association of breast cancer odds with background parenchymal enhancement quantified using a fully automated method at MRI: The IMAGINE study
    Journal Article

    Watt, G. P.; Thakran, S.; Sung, J. S.; Jochelson, M. S.; Lobbes, M. B. I.; Weinstein, S. P.; Bradbury, A. R.; Buys, S. S.; Morris, E. A.; Apte, A.; more...
    Radiology (2023)

    Fulltext@MSK | Save
  • Is axillary staging obsolete in early breast cancer?
    Review

    Morrow, M.
    Surgical Oncology Clinics of North America (2023)

    Fulltext@MSK | Save
  • An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor–positive breast cancer
    Journal Article

    Chandarlapaty, S.; Dickler, M. N.; Perez Fidalgo, J. A.; Villanueva-Vázquez, R.; Giltnane, J.; Gates, M.; Chang, C. W.; Cheeti, S.; Fredrickson, J.; Wang, X.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Axillary lymph node dissection: Dead or still alive?
    Review

    Beck, A. C.; Morrow, M.
    Breast (2023)

    Fulltext@MSK | Save
  • Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: A matching-adjusted indirect comparison
    Journal Article

    Rugo, H. S.; Harmer, V.; O’Shaughnessy, J.; Jhaveri, K.; Tolaney, S. M.; Cardoso, F.; Bardia, A.; Maheshwari, V. K.; Tripathi, S.; Haftchenary, S.; more...
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer
    Journal Article

    Bardia, A.; Mayer, I.; Winer, E.; Linden, H. M.; Ma, C. X.; Parker, B. A.; Bellet, M.; Arteaga, C. L.; Cheeti, S.; Gates, M.; more...
    Breast Cancer Research and Treatment (2023)

    Fulltext@MSK | Save
  • Can we forgo sentinel lymph node biopsy in women aged ≥ 50 years with early-stage hormone-receptor-positive HER2-negative special histologic subtype breast cancer?
    Journal Article

    Knape, N.; Park, J. H.; Agala, C. B.; Spanheimer, P.; Morrow, M.; Downs-Canner, S.; Baldwin, X. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden
    Journal Article

    Lee, M. K.; Montagna, G.; Pilewskie, M. L.; Sevilimedu, V.; Morrow, M.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration
    Journal Article

    Rios-Doria, E.; Filippova, O. T.; Straubhar, A. M.; Chi, A.; Awowole, I.; Sandhu, J.; Broach, V.; Mueller, J. J.; Gardner, G. J.; Jewell, E. L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save